← Back to Patent Explorer
US4340592A Expired / Lapsed US ⏱️ 0.0 years remaining

Nutrient compositions and method of administering the same

Assignee: Individual
•
Filing: 1981-01-26
•
Granted: 1982-07-20
•
Expires: 2001-01-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Method for administering dipeptides and tripeptides to mammals for dietary purposes, orally, intragastrointestinally and intravenously. The tripeptides and dipeptides, contain glycine as the amino acid residue which provides the N-terminal amino acid grouping. Other amino acid residues contained in the tripeptide or dipeptide can include leucine, isoleucine, valine, threonine, methionine, phenylalanine, lysine, tryptophan, alanine, arginine, histidine, alanine, proline and glutamic acid.

Inventors

  • 👤 Siamak A. Adibi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 02:28
CPC Classifications
A; A23; A23L; A23L33/00; A23L33/10; A23L33/17; A23L33/18

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 47 words
A nutrient composition comprising an aqueous solution containing from one to 20 weight percent of at least two oligopeptides selected from the class consisting of dipeptides and tripeptides, wherein the said oligopeptides include a single glycine unit which is the N-terminal amino acid residue of the oligopeptide.
Claim 2
Dependent Claim 47 words
A nutrient composition comprising an aqueous solution containing from one to 20 weight percent of at least two oligopeptides selected from the class consisting of dipeptides and tripeptides, wherein the said oligopeptides include a single glycine unit which is the N-terminal amino acid residue of the oligopeptide.
Claim 3
Dependent Claim 26 words
A nutrient composition of claim 1 wherein the said tripeptides are selected from the class consisting of: Glycine-leucine-leucine, glycine-isoleucine-isoleucine, glycine-valine-valine, glycine-threonine-threonine, glycine-methionine-methionine, glycine-phenylalanine-phenylalanine, glycine-lysine-lysine and glycine-tryptophan-tryptophan.
Claim 4
Dependent Claim 23 words
A nutrient composition of claim 1 including other nutrients selected from the class consisting of fats, glucose, oligosaccharides, minerals, trace elements and vitamins.
Claim 5
Dependent Claim 18 words
A nutrient composition of claim 1 including oligopeptides having amino acid residues of all the essential amino acids.
Claim 6
Dependent Claim 18 words
A nutrient composition including the composition of claim 4 and at least one oligopeptide of non-essential amino acids.
Claim 7
Dependent Claim 26 words
A nutrient composition of claim 1 wherein the said dipeptides are selected from the class consisting of: glycine-isoleucine, glycine-leucine, glycine-lysine, glycine-methionine, glycine-phenylalanine, glycine-threonine, glycine-tryptophan and glycine-valine.
Claim 8
Dependent Claim 25 words
A method of administering a nutrient composition to a living mammal which comprises orally introducing into the said mammal the aqueous solution of claim 1.
Claim 9
Dependent Claim 24 words
The method of administering a nutrient composition to a living mammal which comprises parenterally introducing into said mammal the aqueous solution of claim 1.
Claim 10
Dependent Claim 24 words
The method of administering a nutrient composition to a living mammal which comprises intragastrointestinally introducing into said mammal the aqueous solution of claim 1.
Claim 11
Dependent Claim 28 words
The method of administering a nutrient composition to a living mammal which comprises intravenously injecting the aqueous solution of claim 1 into a periperal vein of said mammal.
Claim 12
Dependent Claim 42 words
The method of administering a nutrient composition to a living mammal which comprises merging a stream of the aqueous solution of claim 1 with a stream of another aqueous parenteral solution and injecting the resulting merged stream intravenously into the said mammal.
Claim 13
Dependent Claim 14 words
The method of claim 7 wherein the said living mammal is a living human.

References Cited (Backward Citations)

US4095000A Cited
US4127534A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-07-19 1986-01-18 1986-07-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-07-19 1990-01-18 1990-07-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-07-19 1994-01-18 1994-07-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag